Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (221-230 of 358) with videos related to

Pageof 36
Sort By:
Pharmacogenomics|May 24, 2018
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapyJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitisStefano Bonora, Gianluigi Zanusso, Riccardo Raiteri, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic VariantsJessica Cusato, Valeria Avataneo, Miriam Antonucci, et al.
Frontiers in Microbiology|April 18, 2022
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index CasesMattia Trunfio, Lorenzo Richiardi, Francesca Alladio, et al.
Le Infezioni in Medicina|June 23, 2018
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathySilvia Scabini, Mattia Trunfio, Veronica Pirriatore, et al.
Clinical Pharmacokinetics|November 26, 2008
Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibiaSilvia Garazzino, Alessandro Aprato, Lorena Baietto, et al.
Antiviral Therapy|January 28, 2021
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativityMattia Trunfio, Elena Salvador, Alberto Gaviraghi, et al.
CNS Spectrums|May 28, 2019
Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective studyAlessandro Di Stefano, Chiara Alcantarini, Cristiana Atzori, et al.
AIDS (London, England)|July 24, 2020
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIVMattia Trunfio, Walter Rugge, Lorenzo Mighetto, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 31, 2023
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment RegimenGiacomo Stroffolini, Alessandro Lazzaro, Ambra Barco, et al.
Pageof 36

Showing results (221-230 of 358) with videos related to

Sort By:
Pageof 36
Pharmacogenomics|May 24, 2018
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapyJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitisStefano Bonora, Gianluigi Zanusso, Riccardo Raiteri, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic VariantsJessica Cusato, Valeria Avataneo, Miriam Antonucci, et al.
Frontiers in Microbiology|April 18, 2022
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index CasesMattia Trunfio, Lorenzo Richiardi, Francesca Alladio, et al.
Le Infezioni in Medicina|June 23, 2018
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathySilvia Scabini, Mattia Trunfio, Veronica Pirriatore, et al.
Clinical Pharmacokinetics|November 26, 2008
Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibiaSilvia Garazzino, Alessandro Aprato, Lorena Baietto, et al.
Antiviral Therapy|January 28, 2021
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativityMattia Trunfio, Elena Salvador, Alberto Gaviraghi, et al.
CNS Spectrums|May 28, 2019
Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective studyAlessandro Di Stefano, Chiara Alcantarini, Cristiana Atzori, et al.
AIDS (London, England)|July 24, 2020
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIVMattia Trunfio, Walter Rugge, Lorenzo Mighetto, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 31, 2023
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment RegimenGiacomo Stroffolini, Alessandro Lazzaro, Ambra Barco, et al.
Pageof 36